samedan logo
 
 
 
spacer
home > ebr > summer 2020 > surfacing missed opportunities
PUBLICATIONS
European Biopharmaceutical Review

Surfacing Missed Opportunities

The trouble with working inside the usual boundaries is that companies don’t know what they don’t know. This means they go on doing what they have always done, unaware of opportunities they might be missing.

In the consumer world, smartphones and clever apps are transforming people’s visibility and providing new insights, for example, into people’s personal spending, or consumption habits, which, in turn, help buyers change their behaviour and make better choices. Now, the same needs to happen in the life science industry, from identifying where drugs companies are missing opportunities to market their products, to optimising submissions planning right back to R&D and clinical trials activity.

The key to achieving this is unifying regulatory information management right across the global organisation – encompassing all regional affiliates – to create a clear line of sight across all current product registrations and marketing authorisation submission activity. As long as companies retain one means of managing data, documents, and submissions at a corporate level, and individual approaches at a country level, enterprise-wide visibility will be compromised.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
David Gwyn is Vice President of Life Science Solutions at Amplexor in North America. He has more than 25 years’ experience in the life science industry, delivering high impact content management and collaboration solutions for clients.
spacer
David Gwyn
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ESGE Medtronic Artificial Intelligence Research Award could help prevent almost 100,000 more colorectal cancers across Europe

The European Society of Gastrointestinal Endoscopy (ESGE) and Medtronic has collaborated to create the AI Research Award to support application of AI in the field of colonoscopy. Medtronic will support this Research Award through provision of 75 GI Genius™ platforms to the award winning research projects. The total investment from Medtronic, including both the value of the technology loan, research and training for AI exceeds €1.5million
More info >>

White Papers

The Emerging Use of Social Media in Orphan Disease Drug Research

Worldwide Clinical Trials Ltd

The use of various social media platforms, such as Twitter, Instagram, Facebook, and LinkedIn, for dissemination of clinical trial information has created a cornucopia of possibilities enabling clinical trial performance. Characterized by a people-to-people immediacy, social media permits extraordinarily adaptive modification of study information in real-time, and it does so in a highly targeted fashion.
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement